FIGURE 2
FROM:
Correction of Metabolic, Craniofacial, and Neurologic Abnormalities in MPS I Mice Treated at Birth with Adeno-associated Virus Vector Transducing the Human 
-L-Iduronidase Gene
Seth D. Hartung, Joel L. Frandsen, Dao Pan, Brenda L. Koniar, Patrick Graupman, Roland Gunther, Walter C. Low, Chester B. Whitley and R. Scott McIvor
BACK TO ARTICLEFigure 2.
Effects of AAV-IDUA treatment on Idua
-/- weights. Animals were weighed every 4 weeks beginning 1 month after vector injection. Bars depict the mean percentage difference from same sex Idua
+/- control (
SEM) for n = 6 animals per group. At each time point, the heterozygous control group is defined as 100%.
